KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Equity Ratio: 2009-2024

Historic Equity Ratio for Chemed (CHE) over the last 16 years, with FY2024 value amounting to 0.67.

  • Chemed's Equity Ratio fell 504.76% to 0.66 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16, marking a year-over-year decrease of 1075.66%. This contributed to the annual value of 0.67 for FY2024, which is 97.44% up from last year.
  • Latest data reveals that Chemed reported Equity Ratio of 0.67 as of FY2024, which was up 97.44% from 0.66 recorded in FY2023.
  • Chemed's 5-year Equity Ratio high stood at 0.67 for FY2024, and its period low was 0.46 during FY2021.
  • Its 5-year average for Equity Ratio is 0.6, with a median of 0.63 in 2020.
  • As far as peak fluctuations go, Chemed's Equity Ratio crashed by 2609.13% in 2021, and later soared by 1990.78% in 2023.
  • Chemed's Equity Ratio (Annual) stood at 0.63 in 2020, then decreased by 26.09% to 0.46 in 2021, then grew by 19.32% to 0.55 in 2022, then rose by 19.91% to 0.66 in 2023, then increased by 0.97% to 0.67 in 2024.
  • Its last three reported values are 0.67 in FY2024, 0.66 for FY2023, and 0.55 during FY2022.